The Global Infusion Pumps Market has been projected to grow at the CAGR of 5.2% market during 2017-2025. In 2016, the market has generated a revenue of $ 3.45 billion and now it has been expected to reach up to $ 5.43 billion in terms of revenue by 2025.
The infusion pumps expected to show significant growth during the forecast period due to increasing incidence of chronic disorders, rising adoption of insulin pumps, innovation in infusion pumps and extensive R&D activities in development of novel infusion pump driving the growth of infusion pumps market globally.
Market Segment Insights
For the purpose of study global infusion pumps, the market is studied on the basis of type of product such as volumetric pumps, syringe pumps, ambulatory pump, enteral infusion pumps, insulin pumps, implantable pumps, patient controlled pumps and infusion pump disposables. On the other hand, based on application market is categorized as chemotherapy, pediatrics, pain management, gastroenterology, hematology and diabetes.
In the base year 2016, North America followed by Europe held largest market share in global infusion pumps market due to early adoption of new technologies, upsurge funding by the government agencies and private organizations, large number of key manufacturers and higher healthcare awareness driving the market growth in these region. However, Asia Pacific is anticipated to show highest CAGR during forecast period due to factors such as developing healthcare infrastructure and increasing disposable income among general population expected to drive the market growth in Asia Pacific region.
Market Competition Assessment:
The major players currently operating in the global infusion pumps market include B. Braun Melsungen AG, Baxter International Inc., CareFusion Corp., F. Hoffmann-la Roche Ltd., Hospira, Johnson & Johnson Corp., Medtronic Plc., Pfizer Inc., Smiths Medical and Terumo Corp.
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
2. Executive Summary
2.1. Global Infusion Pumps Market Portraiture
2.2. Global Infusion Pumps Market, by Product, 2016 ($ Billion)
2.3. Global Infusion Pumps Market, by Application, 2016 ($ Billion)
2.4. Global Infusion Pumps Market, by Geography, 2016 (Value %)
3. Global Infusion Pumps Market Analysis
3.1. Global Infusion Pumps Market Overview
3.2. Market Dynamics
3.2.1. Market Drivers
3.3. Attractive Investment Proposition, 2016
3.4. Competitive Landscape Assessment, by Key Market Players
4. Global Infusion Pumps Market, by Product, 2015–2025 ($ Billion)
4.2. Volumetric Pumps
4.3. Syringe Pumps
4.4. Ambulatory Pumps
4.5. Enteral Infusion Pumps
4.6. Insulin Pumps
4.7. Implantable Pumps
4.8. Patient Controlled Pumps
4.9. Infusion Pump Disposables
5. Global Infusion Pumps Market, by Application, 2015–2025 ($ Billion)
5.4. Pain Management
6. Global Infusion Pumps Market, by Geography, 2015-2025 ($ Billion)
6.1. North America
6.2.4. Rest of Europe
6.3. Asia Pacific
6.3.3. Rest of Asia Pacific
6.4. Latin America (LATAM)
6.4.3. Rest of Latin America
6.5. Middle East and Africa (MEA)
7. Company Profiles
7.1. B. Braun Melsungen AG
7.2. Baxter International Inc.
7.3. CareFusion Corporation
7.4. F. Hoffmann-la Roche Ltd.
7.6. Johnson & Johnson Corporation
7.7. Medtronic Plc.
7.8. Pfizer Inc.
7.9. Smiths Medical
7.10. Terumo Corp.